226 related articles for article (PubMed ID: 26267611)
1. Management of pediatric renal tumor: Past and future trials of the Japan Wilms Tumor Study Group.
Oue T; Fukuzawa M; Koshinaga T; Okita H; Nozaki M; Chin M; Kaneko Y; Tanaka Y; Haruta M; Tsuchiya K; Kuwajima S; Takimoto T
Pediatr Int; 2015 Oct; 57(5):828-31. PubMed ID: 26267611
[TBL] [Abstract][Full Text] [Related]
2. Outcome of renal tumors registered in Japan Wilms Tumor Study-2 (JWiTS-2): A report from the Japan Children's Cancer Group (JCCG).
Koshinaga T; Takimoto T; Oue T; Okita H; Tanaka Y; Nozaki M; Tsuchiya K; Inoue E; Haruta M; Kaneko Y; Fukuzawa M
Pediatr Blood Cancer; 2018 Jul; 65(7):e27056. PubMed ID: 29630767
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
[TBL] [Abstract][Full Text] [Related]
4. Outcome of pediatric renal tumor treated using the Japan Wilms Tumor Study-1 (JWiTS-1) protocol: a report from the JWiTS group.
Oue T; Fukuzawa M; Okita H; Mugishima H; Horie H; Hata J; Saito M; Nozaki M; Chin M; Nakadate H; Hinotsu S; Koshinaga T; Kaneko Y; Kitano Y; Tanaka Y;
Pediatr Surg Int; 2009 Nov; 25(11):923-9. PubMed ID: 19701757
[TBL] [Abstract][Full Text] [Related]
5. Bilateral Wilms tumors treated according to the Japan Wilms Tumor Study Group protocol.
Oue T; Koshinaga T; Okita H; Kaneko Y; Hinotsu S; Fukuzawa M
Pediatr Blood Cancer; 2014 Jul; 61(7):1184-9. PubMed ID: 24623612
[TBL] [Abstract][Full Text] [Related]
6. Factors responsible for stage III disease in patients with Wilms tumor enrolled in the JWiTS-2 study.
Oue T; Fukumoto K; Souzaki R; Takimoto T; Koshinaga T;
Pediatr Surg Int; 2019 Oct; 35(10):1095-1099. PubMed ID: 31396736
[TBL] [Abstract][Full Text] [Related]
7. [Treatment strategy for children with Wilms tumor].
Fukuzawa M
Nihon Geka Gakkai Zasshi; 2005 Jul; 106(7):422-6. PubMed ID: 16045185
[TBL] [Abstract][Full Text] [Related]
8. Results of the Third AIEOP Cooperative Protocol on Wilms Tumor (TW2003) and Related Considerations.
Spreafico F; Biasoni D; Lo Vullo S; Gandola L; D'Angelo P; Terenziani M; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Morosi C; Perotti D; Catania S; Bellani FF; Collini P;
J Urol; 2017 Nov; 198(5):1138-1145. PubMed ID: 28655531
[TBL] [Abstract][Full Text] [Related]
9. Wilms tumor: Successes and challenges in management outside of cooperative clinical trials.
Rabeh W; Akel S; Eid T; Muwakkit S; Abboud M; El Solh H; Saab R
Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):20-5. PubMed ID: 26802622
[TBL] [Abstract][Full Text] [Related]
10. Management of Wilms tumor: current standard of care.
Sonn G; Shortliffe LM
Nat Clin Pract Urol; 2008 Oct; 5(10):551-60. PubMed ID: 18836464
[TBL] [Abstract][Full Text] [Related]
11. Current standards of care and future directions for "high-risk" pediatric renal tumors: Anaplastic Wilms tumor and Rhabdoid tumor.
Geller JI
Urol Oncol; 2016 Jan; 34(1):50-6. PubMed ID: 26612481
[TBL] [Abstract][Full Text] [Related]
12. [Wilms' tumor: reached progress and future prospects].
Tamaro P
Arch Ital Urol Androl; 1997 Sep; 69(4):227-32. PubMed ID: 9417294
[TBL] [Abstract][Full Text] [Related]
13. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
14. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
Aoba T; Urushihara N; Fukumoto K; Furuta S; Fukuzawa H; Mitsunaga M; Watanabe K; Yamoto M; Miyake H; Koyama M; Iwabuchi H; Koike J; Tatsunami S; Wakisaka M; Kitagawa H
J Pediatr Surg; 2012 Dec; 47(12):2210-5. PubMed ID: 23217878
[TBL] [Abstract][Full Text] [Related]
15. Management of children with a Wilms tumor in Malawi, sub-Saharan Africa.
Israels T; Borgstein E; Pidini D; Chagaluka G; de Kraker J; Kamiza S; Molyneux EM
J Pediatr Hematol Oncol; 2012 Nov; 34(8):606-10. PubMed ID: 22767130
[TBL] [Abstract][Full Text] [Related]
16. The evolution of treatment for Wilms tumor.
Green DM
J Pediatr Surg; 2013 Jan; 48(1):14-9. PubMed ID: 23331787
[TBL] [Abstract][Full Text] [Related]
17. Bilateral Wilms' tumor: long-term survival and some epidemiological features.
Coppes MJ; de Kraker J; van Dijken PJ; Perry HJ; Delemarre JF; Tournade MF; Lemerle J; Voûte PA
J Clin Oncol; 1989 Mar; 7(3):310-5. PubMed ID: 2537383
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes in adults with favorable histologic type Wilms tumor-an update from the National Wilms Tumor Study Group.
Kalapurakal JA; Nan B; Norkool P; Coppes M; Perlman E; Beckwith B; Ritchey M; Breslow N; Grundy P; D'angio GJ; Green DM; Thomas PR
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1379-84. PubMed ID: 15590168
[TBL] [Abstract][Full Text] [Related]
19. Current challenges in Wilms' tumor management.
Gommersall LM; Arya M; Mushtaq I; Duffy P
Nat Clin Pract Oncol; 2005 Jun; 2(6):298-304; quiz 1 p following 324. PubMed ID: 16264987
[TBL] [Abstract][Full Text] [Related]
20. Outcomes according to treatment using an established protocol in patients with bilateral Wilms' tumor: A national Canadian population-based study.
Bednarek OL; Seemann N; Brzezinski J; Lorenzo A; Fernandez CV; Romao RLP
J Pediatr Surg; 2023 May; 58(5):1014-1017. PubMed ID: 36797114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
